DnA9V

258. Fiori E, Lamazza A, De CA, Bononi M, Volpino P, Schillaci A, et al. Palliative management
of malignant rectosigmoidal obstruction. Colostomy vs. endoscopic stenting. A randomized
prospective trial. Anticancer Res. 2004;24(1):265-8.
259. Xinopoulos D, Dimitroulopoulos D, Theodosopoulos T, Tsamakidis K, Bitsakou G, Plataniotis
G, et al. Stenting or stoma creation for patients with inoperable malignant colonic obstructions
Results of a study and cost-effectiveness analysis. Surg Endosc. 2004;18(3):421-6.
260. Feuer DJ, Broadley KE. Corticosteroids for the resolution of malignant bowel obstruction in
advanced gynaecological and gastrointestinal cancer. Cochrane Database Syst Rev. 2000;(2):
CD001219.
261. Mercadante S, Casuccio A, Mangione S. Medical Treatment for Inoperable Malignant Bowel
Obstruction: A Qualitative Systematic Review. Journal of Pain and Symptom Management.
2007;33(2):217-23.
262. Kichian K, Vain BG. Jaundice, ascites, and hepatic encephalopathy. In: Doyle D, Hanks G,
Chreney N, Calman K, editors. Oxford Textbook of Palliative Medicine. Third ed. Oxford:
Oxford University Press; 2004.
263. Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment.
Eur J Cancer. 2006;42(5):589-97.
264. Smith HS, Busracamwongs A. Management of hiccups in the palliative care population. Am
J Hosp Palliat Care. 2003;20(2):149-54.
265. Fishman M. Overview of hiccups. In: UpToDate RB, editor. Waltham, MA: UpToDate;
2007.
266. Royal College of Nursing and National Institute for Health and Clinical Excellence. The
management of pressure ulcers in primary and secondary care A Clinical Practice Guideline.
London: Royal College of Nursing; 2005.
267. Cullum N, McInnes E, Bell-Syer SE, Legood R, Cullum N, McInnes E, et al. Support surfaces
for pressure ulcer prevention.[see comment][update of Cochrane Database Syst Rev. 2000;(2):
CD001735; PMID: 10796662]. [Review] [101 refs]. Cochrane Database of Systematic Reviews.
2004;(3):CD001735.
268. Reddy M, Gill SS, Rochon PA, Reddy M, Gill SS, Rochon PA. Preventing pressure ulcers: a
systematic review. JAMA. 2006;296(8):974-84.
269. Gallart E, Fuentelsaz C, Vivas G, Garnacho I, Font L, Aran R. Estudio experimental para
comprobar la efectividad de los ácidos grasos hiperoxigenados en la prevenciónde las úlceras
por presión en pacientes ingresados. ENFERM CLIN. 1928;2001;11(5):179-83.
270. Flock P. Pilot study to determine the effectiveness of diamorphine gel to control pressure
ulcer pain. J PAIN SYMPTOM MANAGE. 2003;25(6):547-54.
271. Adderley U. Topical agents and dressings for fungating wounds. Cochrane Database of Systematic
Reviews. 2007;2, 2007.
272. Murtagh FE, ddington-Hall J, Higginson IJ. The prevalence of symptoms in end-stage renal
disease: a systematic review. Adv Chronic Kidney Dis. 2007;14(1):82-99.
273. Heinrich WL. Uremic pruritus. In: UpToDate RB, editor. UpToDate.Waltham,MA: UpTo-
Date; 2007.
274. Lidstone V, Thorns A. Pruritus in cancer patients. Cancer Treat Rev. 2001;27(5):305-12.
302 GUÍAS DE PRÁCTICA CLÍNICA EN EL SNS